CEO of Caredx Inc (30-Year Financial, Insider Trades) Peter Maag (insider trades) sold 30,000 shares of CDNA on 05/19/2020 at an average price of $32.24 a share. The total sale was $967,200.
CareDx Inc is a commercial stage company. It develops, markets and delivers a diagnostic surveillance solution for heart transplant recipients to help clinicians make personalized treatment decisions throughout a transplant patient's lifetime. CareDx Inc has a market cap of $1.34 billion; its shares were traded at around $30.71 with and P/S ratio of 9.36. GuruFocus has detected 1 severe warning sign with CareDx Inc. .
CEO Recent Trades:
- CEO Peter Maag sold 30,000 shares of CDNA stock on 05/19/2020 at the average price of $32.24. The price of the stock has decreased by 4.75% since.
CFO Recent Trades:
- CFO Michael Brian Bell sold 57,136 shares of CDNA stock on 05/06/2020 at the average price of $29. The price of the stock has increased by 5.9% since.
Directors and Officers Recent Trades:
- Director George Bickerstaff sold 10,000 shares of CDNA stock on 05/13/2020 at the average price of $27.65. The price of the stock has increased by 11.07% since.
- Director Michael Goldberg sold 10,000 shares of CDNA stock on 05/11/2020 at the average price of $29.86. The price of the stock has increased by 2.85% since.
- Director William A Hagstrom sold 15,000 shares of CDNA stock on 05/06/2020 at the average price of $29.12. The price of the stock has increased by 5.46% since.
For the complete insider trading history of CDNA, click here
.
